FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381597968> ?p ?o ?g. }

• W4381597968 endingPage "67" @default.
• W4381597968 startingPage "55" @default.
• W4381597968 abstract "Background Intravenous glucocorticoid (IVGC) remains the main treatment for moderate-to-severe and active thyroid-associated ophthalmopathy (TAO). However, a substantial number (20–30%) of active moderate-to-severe TAO patients may not respond to IVGC. Some patients may have disease progression despite IVGC treatment or relapse after steroid withdrawal.Objectives To analyze risk factors for clinical activity and predictive factors for clinical outcomes of 4.5 g IVGC therapy in patients with moderate-to-severe TAO.Design and methods Our study was performed in two steps: step 1 involved 110 moderate-to-severe TAO patients and analyzed risk factors for TAO activity; step 2 involved 53 active moderate-to-severe TAO patients from step 1 who were treated with 4.5 g IVGC therapy and analyzed predictive factors for clinical outcomes of IVGC therapy. Multivariate logistic regression analysis was used to identify the independent predictors and establish the predictive model.Results Abnormal TRAb (OR = 4.717; P = 0.019) and the percentage of CD3+CD4+ T cell (OR = 1.092; P = 0.028) were independently associated with the activity of moderate-to-severe TAO patients. The pretreatment CAS-max in both eyes (OR = 7.221; P = 0.013) and the percentage of pretreatment CD3+T cell (OR = 0.718; P = 0.037) were independently associated with therapeutic efficacy. The pretreatment CAS-max in both eyes (OR = 156.53; P = 0.028) and the percentage of post-treatment CD3+T cell (OR = 0.554; P = 0.043) were independently associated with therapeutic efficacy. Besides, multivariable prediction models were established, which were better in the forecasting aspect than single-variable prediction models.Conclusions Based on the findings of this study, we should monitor the peripheral blood T cell subsets for TAO, which could be helpful to timely judge the condition of clinical manifestation and effect of treatment for TAO patients. Multivariable prediction models have been established, which have great significance for clinical work." @default.
• W4381597968 created "2023-06-23" @default.
• W4381597968 creator A5002706430 @default.
• W4381597968 creator A5005994170 @default.
• W4381597968 creator A5012774046 @default.
• W4381597968 creator A5023089591 @default.
• W4381597968 creator A5028315768 @default.
• W4381597968 creator A5034686146 @default.
• W4381597968 creator A5035890977 @default.
• W4381597968 creator A5045900847 @default.
• W4381597968 creator A5046743882 @default.
• W4381597968 creator A5048494044 @default.
• W4381597968 creator A5053780153 @default.
• W4381597968 creator A5056367333 @default.
• W4381597968 creator A5060507935 @default.
• W4381597968 creator A5067472529 @default.
• W4381597968 creator A5075080019 @default.
• W4381597968 creator A5081502580 @default.
• W4381597968 creator A5082300192 @default.
• W4381597968 creator A5084346518 @default.
• W4381597968 creator A5085467745 @default.
• W4381597968 creator A5088104519 @default.
• W4381597968 creator A5089404235 @default.
• W4381597968 date "2023-06-22" @default.
• W4381597968 modified "2023-10-05" @default.
• W4381597968 title "T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy" @default.
• W4381597968 cites W1856370030 @default.
• W4381597968 cites W188362558 @default.
• W4381597968 cites W1968260895 @default.
• W4381597968 cites W1971482295 @default.
• W4381597968 cites W1971663984 @default.
• W4381597968 cites W1981584095 @default.
• W4381597968 cites W1993971400 @default.
• W4381597968 cites W1997419027 @default.
• W4381597968 cites W2013208761 @default.
• W4381597968 cites W2014983747 @default.
• W4381597968 cites W2027692277 @default.
• W4381597968 cites W2030419597 @default.
• W4381597968 cites W2052365721 @default.
• W4381597968 cites W2052463348 @default.
• W4381597968 cites W2055167616 @default.
• W4381597968 cites W2058247907 @default.
• W4381597968 cites W2072447280 @default.
• W4381597968 cites W2083555335 @default.
• W4381597968 cites W2087860396 @default.
• W4381597968 cites W2093134054 @default.
• W4381597968 cites W2112765640 @default.
• W4381597968 cites W2122371847 @default.
• W4381597968 cites W2133188970 @default.
• W4381597968 cites W2140023383 @default.
• W4381597968 cites W2142123665 @default.
• W4381597968 cites W2152080639 @default.
• W4381597968 cites W2153159377 @default.
• W4381597968 cites W2167654441 @default.
• W4381597968 cites W2171838635 @default.
• W4381597968 cites W2174893517 @default.
• W4381597968 cites W2276509781 @default.
• W4381597968 cites W2288910126 @default.
• W4381597968 cites W2334529247 @default.
• W4381597968 cites W2461126386 @default.
• W4381597968 cites W2611131029 @default.
• W4381597968 cites W2794967904 @default.
• W4381597968 cites W2799918329 @default.
• W4381597968 cites W2902638510 @default.
• W4381597968 cites W2903723179 @default.
• W4381597968 cites W2909622492 @default.
• W4381597968 cites W2918864820 @default.
• W4381597968 cites W2957947066 @default.
• W4381597968 cites W2973648524 @default.
• W4381597968 cites W2998265514 @default.
• W4381597968 cites W3041083540 @default.
• W4381597968 cites W3114925060 @default.
• W4381597968 cites W4210482789 @default.
• W4381597968 cites W4211209010 @default.
• W4381597968 cites W4220657530 @default.
• W4381597968 cites W4246035014 @default.
• W4381597968 doi "https://doi.org/10.1080/07435800.2023.2219734" @default.
• W4381597968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37345481" @default.
• W4381597968 hasPublicationYear "2023" @default.
• W4381597968 type Work @default.
• W4381597968 citedByCount "0" @default.
• W4381597968 crossrefType "journal-article" @default.
• W4381597968 hasAuthorship W4381597968A5002706430 @default.
• W4381597968 hasAuthorship W4381597968A5005994170 @default.
• W4381597968 hasAuthorship W4381597968A5012774046 @default.
• W4381597968 hasAuthorship W4381597968A5023089591 @default.
• W4381597968 hasAuthorship W4381597968A5028315768 @default.
• W4381597968 hasAuthorship W4381597968A5034686146 @default.
• W4381597968 hasAuthorship W4381597968A5035890977 @default.
• W4381597968 hasAuthorship W4381597968A5045900847 @default.
• W4381597968 hasAuthorship W4381597968A5046743882 @default.
• W4381597968 hasAuthorship W4381597968A5048494044 @default.
• W4381597968 hasAuthorship W4381597968A5053780153 @default.
• W4381597968 hasAuthorship W4381597968A5056367333 @default.
• W4381597968 hasAuthorship W4381597968A5060507935 @default.
• W4381597968 hasAuthorship W4381597968A5067472529 @default.
• W4381597968 hasAuthorship W4381597968A5075080019 @default.
• W4381597968 hasAuthorship W4381597968A5081502580 @default.

• next